Interaction between pathogenic bacteria and intrauterine leukocytes triggers alternative molecular signaling cascades leading to labor in women.
Increased risk of preterm labor has been linked to cervicovaginal infection with Ureaplasma urealyticum and group B streptococci. Although various experimental models have been developed to study the role of amniochorion infection in preterm labor, they typically exclude the initial interaction between intrauterine leukocytes (recruited from decidual vessels into the avascular fetal membranes) and infecting bacteria. In this work, we ascertained whether inflammatory molecules secreted by bacterium-activated intrauterine leukocytes stimulate the amniochorion production of mediators involved in human labor. Using a two-step process beginning with placental circulating leukocytes as a proxy for intrauterine leukocytes, we found that coincubation of amniochorion explants with plasma from placental whole blood preincubated with group B streptococci resulted in a significant increase in tumor necrosis factor alpha (TNF-α) and matrix metalloproteinase 9 (MMP-9) levels in tissue. Extensive changes in the connective tissue arrangement and a decrease in collagen content demonstrated the degradation of the extracellular matrix following this treatment. In contrast, plasma from blood preconditioned with U. urealyticum induced a highly significant secretion of interleukin-1β (IL-1β) and prostaglandin E(2) (PGE(2)) by the amniochorion without changes in the extracellular matrix organization or content. These data demonstrate that group B streptococci induce degradation of the amniochorion as a result of MMP-9 production, probably via TNF-α, whereas U. urealyticum stimulates the secretion of PGE(2), probably via IL-1β, potentially stimulating myometrial contraction. Our study provides novel evidence that the immunological cells circulating within the uterine microenvironment respond differentially to an infectious agent, triggering alternative molecular signaling pathways leading to human labor.
Estrada-Gutierrez
Guadalupe
G
Research Direction, Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes, Mexico City, Mexico.
Gomez-Lopez
Nardhy
N
Zaga-Clavellina
Veronica
V
Giono-Cerezo
Silvia
S
Espejel-Nuñez
Aurora
A
Gonzalez-Jimenez
Marco Antonio
MA
Espino y Sosa
Salvador
S
Olson
David M
DM
Vadillo-Ortega
Felipe
F
D000650:Amnion / Q000276:immunology* / Q000378:metabolism; D002823:Chorion / Q000276:immunology* / Q000378:metabolism; D015232:Dinoprostone / Q000378:metabolism; D005260:Female; D006801:Humans; D007249:Inflammation / Q000276:immunology; D053583:Interleukin-1beta / Q000378:metabolism; D015850:Interleukin-6 / Q000378:metabolism; D007962:Leukocytes / Q000276:immunology*; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D007752:Obstetric Labor, Premature / Q000276:immunology*; D009924:Organ Culture Techniques; D010920:Placenta / Q000166:cytology / Q000276:immunology; D011247:Pregnancy; D015398:Signal Transduction; D013292:Streptococcus agalactiae / Q000502:physiology*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D016990:Ureaplasma urealyticum / Q000502:physiology*
D053583:Interleukin-1beta; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D020780:Matrix Metalloproteinase 9; D015232:Dinoprostone
J Med Microbiol. 2000 Jun;49(6):543-552
10847208
J Reprod Immunol. 2009 Jun;80(1-2):122-31
19406481
Reprod Biol Endocrinol. 2003 Dec 02;1:122
14651749
Hum Reprod. 1997 Mar;12(3):586-90
9130764
Biochem J. 1992 Jul 15;285 ( Pt 2):603-11
1379048
Am J Obstet Gynecol. 1988 Aug;159(2):397-404
3136652
Clin Biochem. 1996 Jun;29(3):225-9
8740508
Am J Obstet Gynecol. 1995 Feb;172(2 Pt 1):493-500
7856675
Infect Immun. 2001 Jun;69(6):3906-15
11349058
Am J Clin Pathol. 2003 Aug;120(2):217-24
12931552
Am J Obstet Gynecol. 1990 Mar;162(3):819-25
2316593
Hum Reprod. 1999 Jan;14(1):229-36
10374126
Curr Issues Mol Biol. 1999;1(1-2):53-64
11475701
J Clin Microbiol. 1991 Jul;29(7):1498-503
1885745
Am J Obstet Gynecol. 1981 Sep 15;141(2):184-6
7025636
Biol Reprod. 2002 Dec;67(6):1952-8
12444074
Am J Obstet Gynecol. 1998 Jan;178(1 Pt 1):50-3
9465802
Placenta. 2002 Apr;23(4):257-73
11969336
J Immunol. 2002 Oct 1;169(7):3970-7
12244198
Anal Biochem. 1976 May 7;72:248-54
942051
Biol Reprod. 2004 Oct;71(4):1296-302
15201199
Prostaglandins Leukot Essent Fatty Acids. 1990 Sep;41(1):35-8
2251294
Semin Perinatol. 1988 Oct;12(4):262-79
3065940
Semin Reprod Med. 2007 Jan;25(1):21-39
17205421
J Clin Endocrinol Metab. 1992 Apr;74(4):884-9
1548355
Placenta. 1993 May-Jun;14(3):249-75
8367410
Obstet Gynecol. 1999 Jul;94(1):1-6
10389708
Placenta. 1993 Nov-Dec;14(6):615-25
8153084
Pediatr Infect Dis. 1986 Nov-Dec;5(6 Suppl):S253-7
3540897
Am J Obstet Gynecol. 1996 Apr;174(4):1371-6
8623872
N Engl J Med. 1998 Mar 5;338(10):663-70
9486996
BJOG. 2007 Nov;114(11):1432-5
17949381
J Immunol. 2003 Jan 1;170(1):158-66
12496396
N Engl J Med. 2000 May 18;342(20):1500-7
10816189
Mol Microbiol. 2004 Oct;54(1):23-31
15458402
Prostaglandins. 1994 Dec;48(6):389-99
7892510
Biol Reprod. 1992 May;46(5):772-8
1317222
Am J Obstet Gynecol. 1987 Mar;156(3):649-55
3103451
Obstet Gynecol. 1981 Apr;57(4):479-82
7017516
Am J Pathol. 1995 Jan;146(1):148-56
7856724
Mol Hum Reprod. 2000 Jan;6(1):96-102
10611267
J Clin Microbiol. 1993 Apr;31(4):793-7
8463388
Lancet. 1985 Dec 14;2(8468):1331-3
2866389
Placenta. 2005 Sep-Oct;26(8-9):672-7
16085046
Prostaglandins Leukot Essent Fatty Acids. 1989 Sep;37(3):183-6
2692033
J Reprod Immunol. 2010 Jan;84(1):100-10
19748682
Obstet Gynecol. 1990 Sep;76(3 Pt 1):355-9
2381613
Mol Hum Reprod. 2003 Jan;9(1):41-5
12529419
Prostaglandins. 1989 Jan;37(1):13-22
2785698
Mycoses. 2006 Jan;49(1):6-13
16367811
Scand J Infect Dis. 1992;24(3):317-21
1509236
Matrix Biol. 2005 Jun;24(4):306-12
15955681